Maurice L. Druzin

Professor - University Medical Line, Obstetrics & Gynecology - Maternal Fetal Medicine

Clinical Focus

Obstetrics
Maternal and Fetal Medicine

Academic Appointments

Professor - University Medical Line, Obstetrics & Gynecology - Maternal Fetal Medicine
Professor - University Medical Line (By courtesy), Pediatrics
Member, Maternal & Child Health Research Institute (MCHRI)

Administrative Appointments

Co Chair CMQCC Task force on Hypertensive Disorders of Pregnancy, Californis Department of Public health (2020 - 2020)
Medical co-director, Mid Coastal California Perinatal Outreach Program (MCCPOP) (1991 - Present)
Associate Director OB GYN Residency Training Program, Department OB GYN Stanford University SOM (2016 - Present)
Chair, Committee on Performance, Promotion and Professionalism(CP3), Stanford University School of Medicine (2014 - 2020)
Co-Chair CMQCC Task Force on Preeclampsia Toolkit, California department of Public Health (2013 - 2014)
Division Chief, Maternal Fetal Medicine and Obstetrics, Stanford University School of Medicine/LPCH (1991 - 2013)
Vice Chair, Stanford University School of Medicine - Obstetrics & Gynecology (2005 - 2020)
Associate Dean for Academic Affairs, Stanford University School of Medicine (2001 - 2015)
Director, OBGYN Residency Training Program (2001 - 2016)
Co-Director, Johnson Center for Pregnancy and Newborn Services, Lucile Salter Packard Children's Hospital (1997 - 2013)
California Maternal Quality Care Collaborative, CMQCC (2007 - Present)
Pregnancy Related Mortality Review, CMQCC (2007 - Present)
MQIP Hemorrhage Task Force Committee Meeting, CMQCC (2008 - Present)

Honors & Awards

Outstanding Faculty Professor Obstetrics and Gynecology, Stanford University School of Medicine, Department of Obstetrics and Gynecology (2018-2019)
Albion Walter Hewlett Award, Stanford University School of Medicine, Department of Medicine (April 2018)
ACOG Council of District Chairs Service Recognition Award, California Maternal Care Collaborative's (CMQCC) Preeclampsia Quality Improvement Collaborative (February 2014)
Medical Staff Distinguished Services Award, Lucile Packard Children's Hospital/Stanford Medical Staff (April 2015)
The Franklin G. Ebaugh, Jr. Award for Advising Medical Students, Stanford University (2009)
Outstanding Faculty Professor, Stanford University School of Medicine (2014-2015)
APGO/Martin L. Stone, MD Fund, Advancement of Medical Education in Obstetrics and Gynecology, APGO (2005)
APGO/Ortho-McNeil Faculty Development Award, APGO (2007)

Professional Education

Fellowship: LACplusUSC Medical Center Obstetrics and Gynecology Residency (1979) CA
Residency: University of Colorado Dept of Ob/Gyn (1977) CO
Residency: University of Colorado Dept of Ob/Gyn (1974) CO
Board Certification: American Board of Obstetrics and Gynecology, Maternal and Fetal Medicine (1981)
Board Certification: American Board of Obstetrics and Gynecology, Obstetrics and Gynecology (1980)
Internship: Coronation Hospital (1971)
Medical Education: University of Witwatersrand (1970) South Africa

Contact

Academic druzin@stanford.edu

Alternate Contact Jacquline Laskey Administrative Assistant jlaskey@stanfordchildrens.org Tel: 650-725-8623

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

Obstetrics Clinic 770 Welch Rd Ste 201 Palo Alto CA 94304 Tel: (650) 498-4069 Fax: (650) 725-2062

Additional Clinical Info

Current Research and Scholarly Interests

Antepartum and intrapartum fetal monitoring
Prenatal diagnosis
Medical complications of pregnancy, particularly: SLE, hypertension, diabetes, malignancy

A. Medical Complications of Pregnancy Especially:
1. Pregnancies complicated by S.L.E. and the Antiphospholipid Syndrome
2. Recurrent Fetal Loss
3. Diabetes and Pregnancy
4. Prematurity
5. Hypertension

B. Antepartum Fetal Evaluation and Intrapartum Fetal Evaluation by Means of Electronic Fetal Monitoring.

Clinical Trials

Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Chorioamnionitis Not Recruiting
More
Chorioamnionitis is an infection of the placenta and amniotic membranes (bag of waters) surrounding the baby inside of a pregnant woman prior to delivery. This infection is somewhat common and is routinely treated with antibiotics given to the mother both before and after the baby is born. Currently it is not known what is the best choice of antibiotics to treat this type of infection, but commonly used treatments include Unasyn (ampicillin/sulbactam) or ampicillin/gentamicin. We plan to compare these two different antibiotic regimens to see if one is better than the other at treating and preventing bad outcomes from chorioamnionitis in women and babies.

Stanford is currently not accepting patients for this trial. For more information, please contact Mara Greenberg, 4158672051.

Lead Sponsor
- Stanford University
Stanford Investigators
View full details
Progesterone for Maintenance Tocolysis: A Randomized Placebo Controlled Trial Not Recruiting
More
Preterm delivery is the most common cause of infant morbidity and mortality in the United States. Some women have episodes of preterm labor during their pregnancy which can be temporarily stopped. These women, however, are at high risk for delivering before term. At this time, we do not have sufficient evidence to use any medication to help prevent these women from delivering early. Recently, preliminary studies have shown that progesterone may help prevent some women at high risk for preterm delivery from delivering early. Our study will investigate whether progesterone can help this specific group of women, women with arrested preterm labor, deliver healthy infants at term.

Stanford is currently not accepting patients for this trial. For more information, please contact Elizabeth S Langen, MD, .

Lead Sponsor
- Stanford University
Stanford Investigators
- Yasser El-Sayed, Professor
- Maurice L. Druzin
View full details
Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy. Not Recruiting
More
Enoxaparin is a type of low molecular weight heparin (LMWH), or anticoagulant, used to prevent and treat blood clots. Formation of blood clots, or venous thromboemboli (VTE) in pregnancy can have dangerous and even life-threatening effects on the mother and fetus. Enoxaparin is the preferred medicine to prevent clotting in pregnant patients who are at risk for VTE, because it has been studied to be safe and effective in pregnancy without any harms to the fetus. Although this medication is routinely used and is recommended by several prominent medical groups, the optimal dosing for prevention of VTE is still unclear. The range of standardly prescribed dosing regimens of Enoxaparin includes 40mg daily and 1mg/kg daily, but these two dosing strategies have never been compared in a head to head fashion.

Stanford is currently not accepting patients for this trial. For more information, please contact Mara Greenberg, 4158672051.

Lead Sponsor
- Stanford University
Stanford Investigators
- Maurice L. Druzin
View full details
Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions Not Recruiting
More
Thalassemia is an inherited blood disorder that can result in mild to severe anemia. Regular blood transfusions, which refresh the healthy red blood cell supply, are one treatment for thalassemia. People with thalassemia often experience pain, but the exact source of pain remains unknown. This study will examine how pain varies during the blood transfusion cycle in people with thalassemia who are treated with regular blood transfusions.

Stanford is currently not accepting patients for this trial. For more information, please contact SPECTRUM, .
Lead Sponsor
Stanford Investigators
- Maurice L. Druzin
View full details

Find a doctor

Clinics & Services

Research Resources

Professional Training

Education Resources

Maurice L. Druzin

Professor - University Medical Line, Obstetrics & Gynecology - Maternal Fetal Medicine

Lead Sponsor

Stanford Investigators

Lead Sponsor

Stanford Investigators

Lead Sponsor

Stanford Investigators

Stanford Investigators

2024-25 Courses

2023-24 Courses

2022-23 Courses

2021-22 Courses